Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: The Rancho Bernardo Study

Journal of Human Hypertension

Volumn 24, Issue 8, 2010, Pages 519-524

  Kramer, C K ^a,b   Von Muhlen D ^a   Barrett Connor, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

blood pressure; diabetes; obesity; prospective

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; SYSTOLIC BLOOD PRESSURE; AGE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

AGE DISTRIBUTION; AGED; BLOOD PRESSURE; BODY MASS INDEX; CALIFORNIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 77954815319     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.103     Document Type: Article

References (21)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
3. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 2007; 28: 2937-2943.
4. Meisinger C, Doring A, Heier M. Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the monitoring trends and determinants on cardiovascular diseases/cooperative health research in the Region of Augsburg cohort study. J Hypertens 2008; 26: 1809-1815.
5. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 1980; 111: 705-712.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(Suppl 1): S62-S67.
7. Hypertension detection and follow-up group. The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group. PrevMed 1976; 5: 207-215
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
9. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
10. Izzo R, de Simone G, Chinali M, Iaccarino G, Trimarco V, Rozza F et al. Insufficient control of blood pressure and incident diabetes. Diabetes Care 2009; 32: 845-850.
11. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
12. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
13. Asch S, Wingard DL, Barrett-Connor EL. Are insulin and hypertension independently related? Ann Epidemiol 1991; 1: 231-244.
14. Anneren C, Welsh M, Jansson L. Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter. Am J Physiol Endocrinol Metab 2007; 292: E1183-E1190.
15. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB et al. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 2007; 56: 1898-1904.
16. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-1986.
17. Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J et al. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens 2009; 23: 176-181.
18. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002; 51: 1986-1988.
19. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ et al. The D allele of the ACE I/Department of common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005; 84: 83-89.
20. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J Intern Med 2008; 263: 376-385.
21. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. J Hypertens 2008; 26: 1780-1786.